PUBLIC HEALTH IMPACT AND COST EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION FOR ADULTS IN PUERTO RICO

被引：1
|
作者：
Yang, H. K. [1 ]
O'Brien, M. [1 ]
Chen, J. [2 ]
Grabenstein, J. [1 ]
Dasbach, E. [2 ]
机构：
[1] Merck & Co Inc, West Point, PA USA
[2] Merck & Co Inc, N Wales, PA USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.2203
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A714 / A714
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS AND PUBLIC HEALTH IMPACT OF PNEUMOCOCCAL VACCINATION IN MALAYSIA
    Lee, K. K.
    Hong, L. W.
    Roberts, C. S.
    Lee, V. W.
    Hon, E.
    Strutton, D. R.
    VALUE IN HEALTH, 2011, 14 (07) : A273 - A273
  • [2] COST-EFFECTIVENESS OF CHIKUNGUNYA VACCINATION WITH IXCHIQ IN ADULTS IN PUERTO RICO
    De Roo, A. M.
    Bornheimer, R.
    Ottino, K.
    Houde, L.
    Postiglione, C.
    Meyer, S.
    Vondeling, G. T.
    VALUE IN HEALTH, 2024, 27 (12) : S124 - S124
  • [3] THE PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF PNEUMOCOCCAL CONJUGATE VACCINATION IN ESTONIA
    Posiuniene, I
    Saar, I
    Van de Velde, N.
    VALUE IN HEALTH, 2015, 18 (07) : A583 - A583
  • [4] Public health impact and cost-effectiveness of implementing a ?pre-vaccination screening? strategy with the dengue vaccine in Puerto Rico
    Thommes, Edward
    Coudeville, Laurent
    Muhammad, Riyadh
    Martin, Maria
    Nelson, Christopher B.
    Chit, Ayman
    VACCINE, 2022, 40 (50) : 7343 - 7351
  • [5] Cost-effectiveness of dengue vaccination in Puerto Rico
    Espana, Guido
    Leidner, Andrew J.
    Waterman, Stephen H.
    Perkins, T. Alex
    PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (07):
  • [6] Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost-Effectiveness and Health Impact in US Populations
    Wateska, Angela R.
    Nowalk, Mary Patricia
    Lin, Chyongchiou J.
    Harrison, Lee H.
    Schaffner, William
    Zimmerman, Richard K.
    Smith, Kenneth J.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2020, 58 (04) : 487 - 495
  • [7] ASSESSING THE PUBLIC HEALTH IMPACT AND COST EFFECTIVENESS OF PNEUMOCOCCAL VACCINES FOR ADULTS 65 YEARS OF AGE IN COLOMBIA
    Yang, H. K.
    Dasbach, E. J.
    Guarin, D.
    Hernandez, G.
    Lemos, E.
    VALUE IN HEALTH, 2015, 18 (07) : A871 - A871
  • [8] PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF HERPES ZOSTER VACCINATION FOR OLDER ADULTS IN THE NETHERLANDS
    Van der Pol, S.
    Giannelos, N.
    Joost, S.
    Wilschut, J. C.
    Post, M. J.
    Boersma, C.
    VALUE IN HEALTH, 2022, 25 (12) : S133 - S133
  • [9] Pneumococcal conjugate vaccination in The Gambia: health impact, cost effectiveness and budget implications
    Pecenka, Clint
    Usuf, Effua
    Hossain, Ilias
    Sambou, Sana
    Vodicka, Elisabeth
    Atherly, Deborah
    Mackenzie, Grant
    BMJ GLOBAL HEALTH, 2021, 6 (12):
  • [10] THE COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION IN TAIWAN OLDER ADULTS
    Kuo, K.
    Chen, U.
    Yang, C.
    Wu, Y.
    Gau, C.
    VALUE IN HEALTH, 2018, 21 : S67 - S67
12345